Citation Impact
Citing Papers
Renal function impairment induced by change in posture in patients with cirrhosis and ascites.
1985
Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
2019 StandoutNobel
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis
2009 StandoutNobel
The EGLN-HIF O 2 -Sensing System: Multiple Inputs and Feedbacks
2017 StandoutNobel
Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection
2016
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
Regulation of erythropoiesis by hypoxia-inducible factors
2013
Hypoxia Signaling Cascade for Erythropoietin Production in Hepatocytes
2015
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia
2014
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients
2015 StandoutNobel
Expression of thymosin α1 concatemer in transgenic tomato (Solanum lycopersicum) fruits
2008
AST/ALT Ratio ≥1 Is Not Diagnostic of Cirrhosis in Patients with Chronic Hepatitis C
1998
The role of PHD2 mutations in the pathogenesis of erythrocytosis
2014
Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
2016 StandoutNobel
Color Duplex-Guided Sclerotherapy for the Treatment of Venous Malformations
2000
Mechanisms of hypoxia signalling: new implications for nephrology
2019 StandoutNobel
The history of tomato: From domestication to biopharming
2013 Standout
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance
2018 StandoutNobel
Increased natural cytotoxicity receptor expression and relevant IL‐10 production in NK cells from chronically infected viremic HCV patients
2007
Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
1988 Standout
Guidelines for Sclerotherapy of Varicose Veins (ICD 10: I83.0, I83.1, I83.2, and I83.9)
2004 Standout
Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations
2016 StandoutNobel
Favorable effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascites*1
1994
Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl4-induced hepatocirrhosis.
2018
Update on hypoxia-inducible factors and hydroxylases in oxygen regulatory pathways: from physiology to therapeutics
2017 StandoutNobel
Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease
2004
Interferon α–Stimulated Natural Killer Cells From Patients With Acute Hepatitis C Virus (HCV) Infection Recognize HCV-Infected and Uninfected Hepatoma Cells via DNAX accessory molecule-1
2012 StandoutNobel
Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathways
2014 StandoutNobel
Hemodynamic effects of acute changes in intra-abdominal pressure in patients with cirrhosis
1993
The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels
2007
Pharmacological targeting of the HIF hydroxylases – A new field in medicine development
2016 StandoutNobel
A Systematic Review: The use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy
2011
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Acute kidney injury
2021 Standout
Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial
2001
Hereditary gene mutations in Korean patients with isolated erythrocytosis
2014
Thymosin alpha 1: past clinical experience and future promise
2010
Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility
2010 StandoutNobel
Testosterone Induces Erythrocytosis via Increased Erythropoietin and Suppressed Hepcidin: Evidence for a New Erythropoietin/Hemoglobin Set Point
2013 Standout
Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies
2006
Analysis of a Urinary Biomarker Panel for Clinical Outcomes Assessment in Cirrhosis
2015
New cancer targets emerging from studies of the Von Hippel‐Lindau tumor suppressor protein
2010 StandoutNobel
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosis
1991
Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
2008 StandoutNobel
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
2017 Standout
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection
2016 StandoutNobel
Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. I. Definitions
2006 Standout
The human side of hypoxia‐inducible factor
2008 StandoutNobel
Oxygen homeostasis
2009 StandoutNobel
Continuous prazosin administration in cirrhotic patients: Effects on portal hemodynamics and on liver and renal function
1995
Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease.
1979
Chronobiological study of factors affecting plasma aldosterone concentration in cirrhosis
1986
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
Effect of indomethacin and prostaglandin A, on renal function and plasma renin activity in alcoholic liver disease
1979
Novel Vasopressors in the Treatment of Vasodilatory Shock: A Systematic Review of Angiotensin II, Selepressin, and Terlipressin
2018
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Terlipressin in Hepatorenal Syndrome
2011
Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis
2012
Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation
2004
A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove
2007
A Feedback Loop Involving the Phd3 Prolyl Hydroxylase Tunes the Mammalian Hypoxic Response In Vivo
2009 StandoutNobel
Nuclear entry and export of FIH are mediated by HIF1α and exportin1, respectively
2018 StandoutNobel
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Prolyl 4‐hydroxylases, master regulators of the hypoxia response
2013
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Hyperplasia and hypertrophy of pulmonary neuroepithelial bodies, presumed airway hypoxia sensors, in hypoxia-inducible factor prolyl hydroxylase-deficient mice
2016 StandoutNobel
Erythrocytosis: the HIF pathway in control
2013
Systems biology of oxygen homeostasis
2017 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Renal Syndromes Associated with Nonsteroidal Antiinflammatory Drugs
1984 Standout
Thrombocytosis: Diagnostic Evaluation, Thrombotic Risk Stratification, and Risk-Based Management Strategies
2011
Molecular study of congenital erythrocytosis in 70 unrelated patients revealed a potential causal mutation in less than half of the cases (Where is/are the missing gene(s)?)
2013
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Guidelines for the management of hemophilia
2012 Standout
Works of M. Bernardi being referenced
Alpha-1-thymosin and transcatheter arterial chemoembolization in hepatocellular carcinoma patients: a preliminary experience.
1998
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury
2007
Loss of the JAK2 intramolecular auto‐inhibition mechanism is predicted by structural modelling of a novel exon 12 insertion mutation in a case of idiopathic erythrocytosis
2008
Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H‐M740I) defect
2006
Isolated erythrocytosis: study of 67 patients and identification of three novel germ-line mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene
2011
Terlipressin infusion induces ischemia of breast skin in a cirrothic patient with hepatorenal syndrome
2007
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection
2005
In vitro effect of thymosin‐alpha1 and interferon‐alpha on Th1 and Th2 cytokine synthesis in patients with eAg‐negative chronic hepatitis B
2008
O74 URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) IS A STRONG PREDICTOR OF SHORT-TERM OUTCOME IN PATIENTS WITH ACUTE DECOMPENSATION OF CIRRHOSIS. RELATIONSHIP WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF)
2014
Interferon alpha plus ketoprofen or interferon alpha plus ribavirin in chronic hepatitis C non-responder to interferon alpha alone: results of a pilot study.
1999
Effect Of β Adrenergic Blocking Drugs on the Renin-Aldosterone System, Sodium Excretion, and Renal Hemodynamics in Cirrhosis With Ascites
1977
Low Prevalence of JAK2 Val617Phe Mutation in Patients with Idiopathic Erythrocytosis.
2005
Lamivudine (LAM) plus HBIg combination therapy compared to HBIg or notherapy in preventing hepatitis B (HBV) recurrence after livertransplantation (LT)
2000
Hemodynamic and renal effects of ascites apheresis and reinfusion in patients with cirrhosis
1991
[Transaminases and histological activity in chronic hepatitis C].
1995
Supernormal hemodynamic response to recumbency in cirrhosis without ascites
1989
Study on coagulation profile of patients with cirrhosis of the liver undergoing elective fibreoptic injection sclerotherapy of oesophageal varices.
1984